Critical roles for DNA methylation in embryonic development are well established, but less is known about its roles during trophoblast development, the extraembryonic lineage that gives rise to the placenta. We dissected the role of DNA methylation in trophoblast development by performing mRNA and DNA methylation profiling of Dnmt3a/3b mutants. We find that oocyte-derived methylation plays a major role in regulating trophoblast development but that imprinting of the key placental regulator Ascl2 is only partially responsible for these effects.
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In Brief
Branco et al. dissect the role of DNA methylation in mouse trophoblast development through genome-wide profiling of methylation-deficient mutants. DNA methylation marks carried over from the oocyte play a major role in trophoblast development and cell adhesion, which is partly dependent on silencing of the Polycomb gene Scml2.
INTRODUCTION
Fertilization marks the start of a cascade of rapid epigenetic changes which, coupled to an intricate network of signaling and transcriptional events, ultimately lead from a totipotent zygote to a myriad of differentiated tissues that comprise the embryo as well as supporting extraembryonic tissues. DNA methylation plays essential roles during this time, mainly by mediating silencing of specific genes and transposable elements. Importantly, while genome-wide DNA methylation erasure occurs after fertilization, key genomic regions are kept methylated, including imprinting control regions (ICRs) and murine intracisternal A-particle (IAP) retrotransposons (Lane et al., 2003; Smith et al., 2012) . This epigenetic reprogramming phase is followed by de novo DNA methylation post-implantation, which helps to establish and cement tissue-specific expression programs, thereby driving cell differentiation and organogenesis.
In mammals, three DNA methyltransferases (DNMTs) are responsible for establishing and maintaining DNA methylation profiles: DNMT1 is mainly involved in the maintenance of methylation patterns during replication, whereas DNMT3A and DNMT3B have de novo methylation activity. Mouse knockout (KO) models have shown that all three enzymes are essential for correct embryonic development: Dnmt1 and Dnmt3b KOs are embryonic lethal (Li et al., 1992; Okano et al., 1999) , whereas Dnmt3a KO mice die postnatally (Okano et al., 1999) . The combined double KO (DKO) of Dnmt3a and Dnmt3b has a more severe phenotype than either single KO, with embryos dying at around embryonic day 10.5 (E10.5) (Okano et al., 1999) . Importantly, conditional deletion of Dnmt3a in the oocyte is sufficient to halt embryonic development at E10.5 (Kaneda et al., 2004) , showing that maternal methylation is critical for developmental progression. Maternal KO of Dnmt3l, a catalytically inactive cofactor that interacts with DNMT3A for the establishment of DNA methylation in the oocyte, displays a very similar phenotype (Bourc'his et al., 2001) .
While the role of DNA methylation in the development of the embryo is well established (Auclair et al., 2014) , its importance in the development of the extraembryonic trophoblast lineage remains less clear. Notably, trophoblast tissues are largely hypomethylated when compared with embryonic tissues, in particular at repeat elements, and embryos derived by nuclear transfer from ESCs lacking all three active DNMTs can contribute to extraembryonic tissues when aggregated with wild-type (WT) embryos (Sakaue et al., 2010) . On the other hand, conceptuses from Dnmt3l-null mothers display morphogenic defects across all layers of the placenta (Arima et al., 2006) . To date, comprehensive molecular characterization of the DNA methylation and gene expression alterations linked to these defects is lacking. While they have been largely attributed to the loss of imprinted gene expression, some methylation marks outside of imprinting are also carried over from the oocyte to the blastocyst stage (Smallwood et al., 2011 ), but have not been functionally explored. Indeed, of 1,329 CpG islands (CGIs) that are hypermethylated in oocytes relative to sperm, only 23 are associated with known ICRs (Kobayashi et al., 2012) . In this study, we have performed mRNA sequencing (mRNA-seq) and whole-genome bisulfite sequencing (BS-seq) on trophoblast from Dnmt3a/3b KO mice. We show that the prevailing phenotype is explained by the absence of maternal methylation marks. However, failure to establish correct imprinted gene expression does not explain all observed transcriptional changes. Our data suggest that maternal DNA methylation plays critical roles in the control of cell adhesion in trophoblast giant cells (TGCs) and in the formation of syncytiotrophoblast (SynT).
RESULTS

Absence of Oocyte DNA Methylation Leads to Cell Adhesion Defects
To study the role of DNA methylation in trophoblast development, we used female mice carrying conditional alleles for both Dnmt3a and Dnmt3b (Dodge et al., 2005; Kaneda et al., 2004) , as well as a Zp3-Cre transgene; these were crossed to double heterozygous males, i.e., Dnmt3a +/À ;Dnmt3b +/À ( Figure 1A ).
Deletion of Dnmt3a and Dnmt3b driven by Zp3 expression yields oocytes that lack both enzymes (and virtually all DNA methylation) (Kaneda et al., 2010; Shirane et al., 2013) . We will therefore refer to the group of genotypes resulting from this cross collectively as maternal DKOs (mDKOs), and the individual genotypes derived from this cross as such: DHet for Dnmt3a À/+ ;Dnmt3b À/+ , 3aKO for Dnmt3a
Dnmt3b
À/À , and DKO for Dnmt3a
. To generate a control cohort, we made a separate cross using females without the Zp3-Cre transgene ( Figure 1A ). For simplicity, we will refer to these genotypes as control (Ctrl) genotypes and will not distinguish between the various combinations of WT homozygous and heterozygous alleles generated by this cross. We first dissected conceptuses at E9.5 for morphological characterization. As previously described (Okano et al., 1999) , DKO embryos were severely developmentally delayed, with few defined somites and open neural tube, among other defects, whereas other genotypes exhibited less pronounced abnormalities ( Figure 1B) . However, to our surprise trophoblast tissues showed a very consistent phenotype across all genotypes of the mDKO cohort, with no obvious additional defects being observed in DKO trophoblast over DHet trophoblast ( Figure 1B) . The most prominent characteristic of these tissues was a reduction in the adhesion of TGCs that make up the outermost lining of the implantation site, as these cells were easily dissociated from the remaining tissue when compared with control trophoblast. Maternal deletion of Dnmt3a was sufficient to produce the same phenotype. Histological analysis of Dnmt3a maternal knockout (mKO) trophoblast at E9.5 revealed defects similar to those described for Dnmt3l mKO trophoblast (Arima et al., 2006; Bourc'his et al., 2001) . Namely, Dnmt3a mKOs had a defect in chorio-allantoic fusion that in turn led to a failure in development of the labyrinthine layer, which can be made out in WT trophoblast by finger-like invaginations of the allantoic mesoderm into the chorionic ectoderm layer forming welldefined fetal blood spaces ( Figure 1C ). In addition, while the TGC layer appeared enlarged, this was mostly a result of reduced tissue density, as there was a notable increase in Figure S1 . extracellular space in this layer (Figures 1C and S1A) . It is possible that such spacing only becomes apparent as a result of the histological preparation, but given that WT and mKO tissues were processed in parallel and embedded in the same paraffin block, this is likely to be an expression of the loss of cell adhesion seen in dissected tissues. Cellular adhesion plays key roles in placental development, regulating trophoblast invasiveness into the maternal decidua (Harris et al., 2009; Sutherland et al., 1993) . Importantly, dysregulation of adhesion molecules is commonly observed in placental disorders, including pre-eclampsia and intrauterine growth restriction (Harris et al., 2009; Pollheimer and Knö fler, 2005) . It is therefore plausible that the developmental arrest of methylation-deficient conceptuses is due, at least in part, to alterations in the cellular adhesion profile of trophoblast cells. Figure 1D ). Accordingly, we identified 368 differentially expressed (DE) genes between Ctrl and DHet EPCs, whereas comparison of DHet with 3aKO or 3bKO genotypes yielded only 4 and 6 DE genes, respectively. This strongly suggests that nearly all transcriptional effects are due to oocyte methylation deficiency. Interestingly, we did identify 45 DE genes between DKO and DHet EPCs. As previously described for embryonic tissues (Auclair et al., 2014; Borgel et al., 2010; Hackett et al., 2012) , these include germline-specific genes such as Dazl, Rhox2a, and Tuba3b ( Figure 1E ). These genes are repressed by de novo methylation, as post-zygotic deletion of Dnmt3a/3b is sufficient to cause their upregulation ( Figure S1B ). To focus on the group of oocyte methylation-dependent genes, we selected 137 genes that passed stringent criteria for differential expression in all mDKO genotypes when compared with Ctrl EPCs (Table S1 ). These ''mDKO DE genes'' were made up of 39 upregulated and 98 downregulated genes, and showed very similar expression levels in all mDKO genotypes ( Figure S1C ), suggesting that they are solely dependent on oocyte methylation and not on the presence of DNMTs postfertilization. Concordantly, post-zygotic deletion of Dnmt3a/3b has no effect on the expression of mDKO DE genes ( Figure S1B ). Among the mDKO DE genes were transcription factors and markers relevant to trophoblast development, such as Cdx2, Tpbpa, and Pcdh12 ( Figure 1E , RT-qPCR validation in Figure S1B) . Given that Cdx2 is a key trophoblast stem cell (TSC) transcription factor, we asked whether the TSC niche was affected in Dnmt3a mKO mutants by performing immunofluorescence for CDX2 on sections of E7.5 conceptuses. We found that CDX2 depletion only occurred in the EPC and that the extraembryonic (chorionic) ectoderm, which harbors the TSC niche, remained unaffected ( Figure S1D ), suggesting that loss of CDX2 is unrelated to deregulation of the stem cell compartment, but critically affects the diploid core of the EPC. Key markers of placental development were also affected, including the spongiotrophoblast marker Tpbpa and the glycogen cell precursor marker Pcdh12 (Figures 1E and S1B) . Notably, TGC markers such as Prl3d1/Pl1 were unaffected ( Figure S1B ), suggesting that the observed phenotypic alterations are not due to major defects in the differentiation of this placental cell type.
Loss of Ascl2 Imprinting Only Partially Explains Alterations in mDKO Trophoblast
Oocyte methylation controls several ICRs that are essential for maternal regulation of imprinted genes, which are important for both embryo and trophoblast development. As previously suggested (Arima et al., 2006) , maternal effects on trophoblast development may therefore be a result of loss of specific imprinted genes. To test this hypothesis, we first identified known methylation-dependent imprinted genes within our mDKO DE gene list. Of 79 imprinted genes (paternal and maternal) in our mRNA-seq data, 59 were robustly expressed in EPCs from at least one of the genotypes. However, only five were consistently altered in all mDKO genotypes: Zrsr1, Cd81, Ascl2, Phlda2, and Cdkn1c ( Figure 2A ). Zrsr1 (also known as U2af1-rs1) was upregulated in mDKO EPCs but is unlikely to be involved in the phenotype of mDKO conceptuses, as mice with paternal disomy of chromosome 11 (where Zrsr1 lies) are viable (Cattanach and Kirk, 1985) . Cd81, Cdkn1c, Phlda2, and Ascl2, which are all part of the same imprinting cluster, were all robustly downregulated in mDKO EPCs, as lack of oocyte methylation leads to activation of the non-coding transcript Kcnq1ot1 on the maternal allele, which is known to drive silencing of genes in its vicinity (Peters and Robson, 2008) . Cd81 KO mice are viable (Maecker and Levy, 1997) , and both Cdkn1c and Phlda2 KO placentas are enlarged and show an expansion of the spongiotrophoblast layer, which is a very different phenotype from that observed in mDKOs (Frank et al., 2002; Takahashi et al., 2000) . However, trophoblast from maternal KO of Ascl2 (also known as Mash2) has a severe phenotype mainly characterized by a lack of spongiotrophoblast formation, which leads to embryonic lethality at around E10 (Guillemot et al., 1994) . Given the similarity in phenotype timing to the mDKO trophoblast, as well as the downregulation of spongiotrophoblast marker Tpbpa observed in both models, we decided to test whether Ascl2 downregulation was driving the transcriptional changes seen in mDKO EPCs. For this purpose, we used an Ascl2-lacZ knockin mouse line (Tanaka et al., 1999) to generate mKO conceptuses of Ascl2. We first performed histological analysis at E9.5, which revealed that Ascl2 mKOs had a reduced or absent labyrinthine layer despite having completed chorio-allantoic fusion, and had an enlarged TGC layer ( Figure S2A ), as previously described (Guillemot et al., 1994) . However, unlike Dnmt3a mKO trophoblast, the TGC layer expansion did not involve a significant increase in extracellular space ( Figure S2B ), inferring that TGC cell adhesion is largely intact in Ascl2 mKO mutants. We then isolated E7.5 EPCs from Ascl2 WT and mKO conceptuses for RT-qPCR analyses. We confirmed that Ascl2 repression leads to Tpbpa downregulation, but also found drastic downregulation of Cdx2 and Pcdh12, similar to that seen in Dnmt3 mDKO EPCs ( Figure 2B ). We then extended this analysis by performing mRNA-seq on control and Ascl2 mKO EPCs. We found that, while 43 genes were commonly deregulated between Ascl2 mKO and Dnmt3 mDKO EPCs, there were 94 DE genes that were unique to the Dnmt3 mDKOs ( Figure 2C) . Surprisingly, we also found 216 genes seemingly only deregulated in Ascl2 mKOs. However, when we analyzed the expression of these genes in Dnmt3 mDKO EPCs, we found that they displayed expression changes very similar to those seen in Ascl2 mKOs ( Figure 2D ), but had not passed our stringent criteria for differential expression calling. Importantly, genes deregulated only in the Dnmt3 mDKO EPCs did not display substantial changes in expression in Ascl2 mKOs ( Figure 2D ), demonstrating that these are indeed Ascl2-independent effects. Our data suggest that the majority of transcriptional alterations in mDKO trophoblast are independent of imprinting of a key regulator of placental development. While we cannot completely rule out that the combined loss of imprinting at other loci may drive the gene expression changes seen in mDKOs, it is likely that maternally derived methylation marks outside of ICRs play a major role in trophoblast gene regulation.
mDKO-Affected Genes Are Involved in Trophoblast Development and Adhesion
We decided to focus on the group of 94 genes that were affected in Dnmt3 mDKO but not Ascl2 mKO EPCs. Gene ontology (GO) analysis revealed that this Dnmt3-specific gene list was enriched for genes involved in signal transduction (e.g., Ephb2, Stk10, Pik3ap1, Ptpn3) and the regulation of guanosine triphosphatases (GTPases) (e.g., Asap1, Rgs3, Arhgef4, Rasa4) (Table S2) , whereas no such enrichment was seen in Ascl2-specific genes (Table S3 ). GTPases control many key cellular processes, including focal adhesion and migration/invasion (Menke and Giehl, 2012) , which is consistent with the cellular adhesion defect observed in mDKO trophoblast. Notably, numerous other genes involved in cell adhesion were found to be deregulated in mDKO, such as Itga7, Flnc, Dbnl, and Plxna1. Although the GO term ''cell adhesion'' did not reach significance in our analysis, we noted that many deregulated genes with known roles in cell adhesion and migration lack this annotation (e.g., Asap1, Rasa4, Srgap3, Spry1). Acquisition of an invasive phenotype is a key component of the differentiation process of TGCs (Hemberger et al., 2003; Hunkapiller et al., 2011) . In line with this, Ephb2, a receptor tyrosine kinase that activates Rho family GTPases and is involved in the formation of secondary TGCs (El-Hashash and Kimber, 2006), was downregulated in mDKO EPCs. Other deregulated genes involved in trophoblast differentiation included Gata3 (Ralston et al., 2010), Gjb5 (Kibschull et al., 2014) , Dlx3 (Morasso et al., 1999) , and Alkbh1/2700073G19Rik (Pan et al., 2008) . This prompted us to ask whether mDKO-affected genes were generally associated with trophoblast differentiation. Genes annotated with GO terms associated with trophoblast or placental development were not significantly enriched (although we again found this annotation to be incomplete). However, five out of six tested genes showing upregulation in mDKO EPCs were found to increase in expression during differentiation in vivo ( Figure 3A) , and similar results were obtained during in vitro differentiation of TSCs ( Figure S3 ). To expand on these observations using an annotation-independent approach, we examined the behavior of mDKO-affected genes in expression data from E9.5 WT TGCs (Sher et al., 2013) and found that most of these genes are indeed differentially expressed relative to WT E7.5 EPCs (Figure 3B) . Moreover, their expression in mDKO E7.5 EPCs was well correlated with the expression profile of E9.5 TGCs ( Figure 3B ), indicative of precocious TGC differentiation in mDKO trophoblast. Although some TGC markers (such as Prl3d1) are unchanged in mDKO EPCs ( Figure S1B ), it is likely that deregulation of these TGC-associated genes affects the function of this cell population.
Trophoblast invasion and placental development critically depend on epithelial-to-mesenchymal transition (EMT) (Kokkinos et al., 2010; Parast et al., 2001; Sutherland, 2003 Mmp15 (Tao et al., 2011) and Grhl2 (Cieply et al., 2012) . However, genes widely involved in EMT (e.g., Cdh1, Snai1, Zeb1) were not significantly altered in our E7.5 mRNA-seq data. To test whether an overt EMT phenotype expressed itself at a later developmental stage, we measured the expression of key EMTassociated genes in E9.5 Ctrl and mDKO trophoblast ( Figure 3C ). While we did observe a prominent decrease in the classic epithelial marker Cdh1 (E-cadherin), this was unexpectedly accompanied by a comparable reduction in the mesenchymal marker Cdh2 (N-cadherin). Similarly, while EMT is commonly driven by the expression of Snai1/2 (Snail and Slug), Twist1/2, and Zeb1/2, we found either no change or a robust decrease in the expression of these genes ( Figure 3C ). These results indicate that the cell adhesion changes observed in mDKO trophoblast do not display the characteristics of a classic EMT and may be driven by independent or non-canonical pathways. Contrary to what has been previously suggested (Sakaue et al., 2010) , these data show that oocyte methylation, directly or indirectly, regulates genes that are important for trophoblast differentiation and function. Notably, genes involved in signal transduction pathways that control adhesion and migration are particularly affected.
Methylation-Deficient TSCs Display Cell Adhesion Defects
To further investigate the link between DNA methylation and cellular adhesion, we cultured TSCs null for all three active DNA methyltransferases (Dnmt1, Dnmt3a, and Dnmt3b) and compared them with WT TSCs; both being derived from nuclear transfer embryos (Sakaue et al., 2010) . We observed that WT cells grew as flat epithelial colonies with sharp boundaries as is characteristic of TSCs, whereas triple-knockout (TKO) TSCs did not form distinct colonies but instead exhibited a much more disorganized morphology and a notable loss of discrete colony margins ( Figure 4A ). In WT TSCs, E-cadherin delineated cell-cell junctions within colonies, whereas in TKO TSCs such junctions were less frequent and instead fibroblast-like cytoplasmic protrusions were visible, suggestive of an increased migratory capacity. Furthermore, using an assay to measure cell adhesion to tissue culture wells, we found that TKO TSCs were less adherent than WT cells on uncoated wells ( Figure 4B) . Interestingly, the difference could be rescued by laminin, suggesting that the adhesion defect can be overcome by changing the ECM/substrate composition. These differences were not due to cell differentiation, as TKO TSCs retained expression of key TSC markers (Figures S4 and 6G ). In addition, TSCs derived from Ascl2 mKO trophoblast do not display any morphological abnormalities compared with their WT counterparts (A.B.B. and L.L., unpublished data), ruling out a role for the loss of Ascl2 imprinting in the TKO TSC phenotype.
To test whether loss of cell adhesion in TKO TSCs was driven by deregulation of the same genes identified in mDKO trophoblast, we plotted the expression changes of mDKO DE genes in TKO TSCs using published microarray data ( Figure 4C ) (Sakaue et al., 2010). We found that mDKO upregulated genes are also derepressed in TKO TSCs, supporting a role for DNA (B) Expression of mDKO DE genes in E9.5 TGCs relative to E7.5 EPCs. mRNA-seq data from E9.5 TGCs (Sher et al., 2013) were plotted against our mRNA-seq data for Ctrl (left) or mDKO (right) E7.5 EPCs. Genes upregulated in mDKO EPCs (green) have increased expression in TGCs relative to WT E7.5 EPCs. Similarly, mDKO downregulated genes (red) tend to have lower expression in TGCs. When plotted against mDKO EPC data, the expression of mDKO DE genes is much more comparable with that seen in TGCs.
(C) RT-qPCR of EMT-associated genes in E9.5 trophoblast reveals that mDKO trophoblasts do not exhibit a classic EMT phenotype, although Cdh1 is downregulated. Error bars represent SD. *p < 0.05, **p < 0.01, ***p < 0.001; t test comparing E9.5 with E7.5 (A), or ANOVA with post hoc tests comparing control (Ctrl) and mDKO genotypes (C). See also Figure S3 . methylation in their silencing. In contrast, mDKO downregulated genes were unaffected, suggesting that they are likely indirect effects that occur in the context of trophoblast differentiation. Interestingly, in contrast to TKO TSCs, TKO ESCs showed no changes in the expression of mDKO upregulated genes (Figure 4C ), indicating that TSC-specific transcription factors are required to activate these genes. In line with this hypothesis, we found that mDKO upregulated genes (but not downregulated genes) were enriched for sites bound by both ELF5 and TFAP2C (p = 1.3 3 10 À10 ) (Latos et al., 2015) .
Using RT-qPCR on WT and TKO TSCs we confirmed the derepression of Scml2, which was the top mDKO upregulated gene ( Figure 4D ). Equally concordant with the in vivo data was the downregulation of Spry1, which is a major EGFR signaling regulator that controls cell adhesion and migration (Mekkawy et al., 2014) . We also detected an increase in the expression of the mesenchymal markers Cdh2 and Snai2 ( Figure 4D ), although this was not accompanied by significant changes in Cdh1 or Snai1 ( Figure S4 ), suggesting that, similarly to the mDKO trophoblast, canonical EMT is not involved in the loss of cell adhesion in TKO TSCs.
These results further support a critical role for DNA methylation in the regulation of cell adhesion in trophoblast.
A Subset of mDKO Upregulated Genes Are Controlled by DNA Methylation
We next sought to identify which genes were likely to be regulated through the direct action of DNA methylation. To link gene expression changes with alterations in DNA methylation patterns, we performed whole-genome BS-seq of Ctrl, DHet, and DKO E7. Figure S4 .
and widespread hypomethylation across several genomic features, including gene promoters, gene bodies, and LINE1 retrotransposons ( Figure 5A ). IAP retrotransposons were largely resistant to demethylation, consistent with DNMT1 being sufficient to maintain DNA methylation at these sites (Arand et al., 2012) .
DHet EPCs displayed a slight reduction in DNA methylation across most genomic features ( Figure 5A ). To test whether this was solely due to a loss of oocyte methylation, we compared our data with published data on CGI methylation in oocytes and blastocysts (Kobayashi et al., 2012) . Most CGIs that are partially resistant to demethylation during pre-implantation development are methylated in oocytes ( Figure S5 ) (Smallwood et al., 2011) . We therefore asked whether these reprogramming-resistant CGIs were more likely to be hypomethylated in DHet EPCs when compared with de novo methylated CGIs. Our analysis shows that, overall, both groups of CGIs undergo a similar loss of methylation in DHet EPCs ( Figures 5B and S5 ). In contrast, maternally methylated ICRs displayed a markedly more pronounced loss of methylation ( Figure 5B ). Therefore, it appears that the global hypomethylation seen in EPCs is a result of haploinsufficiency of Dnmt3a and/or Dnmt3b during the de novo methylation phase. However, the lack of correlation between the post-zygotic genotype and expression of mDKO DE genes ( Figure S1C ) argues against a major role of haploinsufficiency in driving the mDKO phenotype.
To exclude these small genome-wide differences in DNA methylation, we performed an unbiased search for differentially methylated regions (DMRs) between DHet and Ctrl EPCs that displayed at least a 20% methylation difference. We identified 6,685 DMRs, nearly all of which (96.6%) involved a loss of methylation in DHet EPCs and were seemingly not enriched at CGIs, promoters, gene bodies, or placental enhancers predicted from the mouse ENCODE project. Around 67% of DMRs had more than 80% methylation in WT oocytes (Kobayashi et al., 2012), whereas only 46% of randomly generated regions passed the threshold, suggesting an important contribution of oocyte methylation to these DMRs. We identified 59 DMRs lying within 20 kb of mDKO DE genes (excluding Ascl2-dependent effects), covering 35 out of 94 DE genes (see examples in Figure 5C) . Surprisingly, these DMRs were associated with both upregulated (n = 14) and downregulated (n = 21) genes. To further probe which gene expression alterations were likely to be directly regulated by DNA methylation, we asked which genes were also affected in TKO TSCs. Notably, 6 out of 14 DMR-associated genes that were upregulated in mDKO EPCs were also more than 2-fold upregulated in TKO TSCs. Five of these genes (Dst, Plekha6, Stk10, Ptpre, and Plcb4) encoded an actin-binding protein, a phospholipid-binding adaptor, a protein kinase, a protein tyrosine phosphatase, and a phospholipase that are implicated in cell adhesion and signal transduction.
These data reveal that a number of oocyte-dependent DMRs are linked to genes deregulated in mDKO EPCs, a subset of which appear to be directly controlled by DNA methylation in a trophoblast-specific manner.
Scml2 Is Hypomethylated in mDKO EPCs and Affects Trophoblast Differentiation and Adhesion
One of the DMRs we identified overlapped Scml2 ( Figure 5C ), which was the most upregulated gene in mDKO EPCs, and was also highly upregulated in TKO TSCs ( Figure 4D ). SCML2 is a non-canonical member of the Polycomb Repressive Complex 1 (PRC1), which plays important epigenetic roles in the establishment of the male germline (Hasegawa et al., 2015; Luo et al., 2015) . We therefore investigated whether Scml2 silencing was important for trophoblast development and adhesion. Firstly, we confirmed that Scml2 upregulation in mDKO EPCs was driven by the maternal deletion of Dnmt3a (Figure 6A) . We then validated the DMR associated with Scml2 using Sequenom MassARRAY, which showed a specific loss of methylation in DHet and DKO EPCs near an intragenic transcription start site (TSS) ( Figure 6B ). This alternative promoter overlaps a CGI (highlighted in Figure 5C ) that is 95% methylated in WT oocytes (losing all methylation in Dnmt3l-null oocytes) and 34% methylated in blastocysts (Kobayashi et al., 2012) , supporting the notion that Scml2 methylation levels are carried over from the oocyte through the pre-implantation phase. Interestingly, maintenance of methylation and silencing of Scml2 are specific to the trophoblast compartment, as methylation in the epiblast is lost and Scml2 is expressed (Figure S6A ). This pattern is also clearly observed when comparing ES and TS cells ( Figure S6A ). Scml2 lies on the X chromosome, but while Scml2 is unmethylated in X-containing sperm (Kobayashi et al., 2012) , no placental Scml2 expression is expected from the paternal allele in females due to imprinted X inactivation in mouse trophoblast. Accordingly, we found no difference in Scml2 expression levels between male and female EPCs within Ctrl or mDKO genotypes. Furthermore, X inactivation appeared unaffected in female DHet EPCs, as Xist expression was unchanged. Importantly, the X-linked nature of Scml2 makes its epigenetic regulation distinguishable from a genomic imprinting mechanism.
To test the effect of Scml2 expression on trophoblast morphology and development, we overexpressed Scml2 in TSCs (Scml2 expression levels in Figure S6C ). When cells were grown under stem cell conditions (fibroblast growth factor [FGF]+), we found no significant differences in morphology or cell adhesion ( Figure S6B ) upon overexpression of Scml2. There were also no detectable differences in the expression of key TSC markers ( Figure S6C ). However, after induction of TSC differentiation by removal of FGF from the medium, Scml2 impaired the expression of Syncytin A (Syna), a marker of SynT-I (which interfaces the maternal blood), while no effect was seen on other differentiation markers, including markers of TGCs and SynT-II ( Figure 6C and data not shown). This suggests that Scml2 silencing is important for SynT-I formation in WT trophoblast. Accordingly, Dnmt3a mKO trophoblast also displayed reduced Syna expression at E7.5 but no alterations in SynT-II markers Synb and Cebpa ( Figure 6D ). While we found that the latter markers were markedly reduced at E9.5, this reflects the absence of the developing labyrinthine layer observed in these mutants. However, the early change seen in Syna expression at E7.5 occurs prior to the morphological establishment of SynT and the labyrinth, suggesting that it is a direct effect of methylation deficiency. In contrast, while Ascl2 mKO trophoblast also displays a reduction in Syna expression at E9.5 due to a reduction of the labyrinthine layer (Oh-McGinnis et al., 2011) , no difference is detected at E7.5 ( Figure S6D ).
As SCML2 was not sufficient to drive cell adhesion defects, we asked whether it was necessary for the phenotype, in combination with other methylation-dependent expression changes. We therefore used CRISPR/Cas9 gene editing to delete Scml2 in TKO TSCs ( Figure S6E ). Strikingly, both Scml2 KO clones that were established displayed a distinct morphology from the parental TKO TSCs, closely resembling the WT colony arrangement ( Figure 6E ). TKO Scml2 KO clones also showed a restored ability to attach to cell culture wells comparable with WT levels ( Figure 6F ). This was not due to changes in cell differentiation state, as cells maintained expression of TSC markers and did not show upregulation of differentiation markers ( Figure 6G and data not shown). Loss of SCML2 did not rescue the rise in Cdh2 expression seen in TKO TSCs ( Figure 6G ). We then asked whether loss of SCML2 was rescuing the cell adhesion defect via modulation of some of the other DE genes identified in mDKO trophoblast. None of the nine genes tested (e.g., Spry1 and Itga7) showed significant differences between TKO TSCs and the TKO Scml2 KO clones ( Figure 6G ), suggesting that Scml2 acts through an independent pathway. Impairment of cell adhesion in TKO TSCs may therefore require both SCML2-dependent pathways together with other methylation-dependent alterations seen in vivo. This is in line with SCML2 overexpression being insufficient to drive cell adhesion changes ( Figure S6B ).
DISCUSSION
Our phenotypic, molecular, and functional analyses show that, contrary to previous reports (Sakaue et al., 2010) , DNA methylation is essential for early trophoblast development. In particular, our work demonstrates that maternal methylation (and its maintenance during pre-implantation development) plays a major regulatory role in trophoblast differentiation and function. This encompasses the need for controlling imprinted genes (Ascl2), but also non-imprinted genes, as demonstrated by the specific example of Scml2, which we have shown to affect Syna expression and cell adhesion. Moreover, methylation at the Scml2 promoter is specifically maintained in the EPC and lost in the epiblast (Figure S6A ), highlighting the need for targeting DNA methylation to the trophoblast compartment at specific loci. Loss of imprinting at methylation-dependent loci other than Ascl2 is also known to have an impact on placental function at later developmental stages (Tunster et al., 2013) , further emphasizing the importance of maternal methylation.
Although non-imprinted oocyte methylation marks have been generally associated with brain-and testis-linked genes (Rutledge et al., 2014) , we have identified critical trophoblast genes that are regulated through maternal DNA methylation (directly or indirectly). Deregulated genes were enriched for signal transduction and regulators of Ras and Rho family GTPases, which are implicated in cell adhesion and migration. Along with the decreased Cdh1 expression seen in E9.5 DHet trophoblast (Figure 3C ), these alterations are in line with the cellular adhesion phenotype seen in mDKO TGCs. Interestingly, links between DNA methylation and EMT have been described in human trophoblast cell lines (Chen et al., 2013a; 2013b) . Epigenetic regulation of mouse trophoblast migration and invasion has also been described through the action of the histone lysine demethylase LSD1 . Similar to some of our observations, LSD1 depletion in TSCs leads to early differentiation onset, which disrupts their epithelial morphology and increases cell migration and invasion. However, we only found one gene (Reep6) in common between mDKO DE genes and LSD1-regulated genes, suggesting that separate epigenetic mechanisms act on different pathways to regulate the crucial processes of cell adhesion and control of invasive behavior in trophoblast.
We uncovered Scml2 as a putative methylation-controlled gene that is kept silent in the trophoblast lineage to allow for appropriate control of cell adhesion and Syna expression. The relatively low methylation levels of Scml2 in Ctrl EPCs suggest that other mechanisms aid in its silencing. We also cannot completely exclude the possibility that Scml2 expression is indirectly controlled by DNA methylation. In the male germline, SCML2 regulates PRC1-dependent ubiquitination of histone H2A either positively or negatively, in a context-and targetdependent manner (Hasegawa et al., 2015) . SCML2 may therefore regulate the expression of genes involved in the control of cell adhesion and migration, as well as of Syna. Notably, based on our Scml2 overexpression experiment, hypomethylation of Scml2 is not sufficient to drive the adhesion defects, implicating maternal DNA methylation more widely in the regulation of cell adhesion and migration, as discussed above. Interestingly, human SCML2 interacts with SFMBT2 , another PcG protein whose ortholog in mouse is essential for placental development (Miri et al., 2013) . Sfmbt2 is a paternally expressed imprinted gene, but silencing of the maternal allele is independent of DNA methylation (Okae et al., 2012) . However, the epigenetic control of SCML2 during human pre-implantation development appears to differ from that of the mouse, as the syntenic region to the DMR that we identified (also at a TSS and CGI in the human) is largely unmethylated in human oocytes and morulae ( Figure S6F ) (Guo et al., 2014) . Differences in placental morphology and organization may ultimately be driven by such gene-regulatory changes throughout evolution. Notably, the X chromosome is particularly enriched in trophoblast-associated genes and has been argued to be an important driver of placental evolution and speciation (Hemberger, 2002) . Along with this argument, it is interesting to note that Scml2 is X-linked exclusively in eutherians.
Our study highlights a critical and widespread role of oocyte methylation in the development of the placenta. Although we cannot completely rule out that other imprinted genes are involved in the early mDKO phenotype we describe, their known placental roles (Tunster et al., 2013) and our data strongly suggest that additional, non-imprinted methylation marks also control trophoblast development. Interestingly, when we measured human oocyte and morula methylation at regions syntenic to our mouse DMRs, we found that CpGs within these regions are generally hypermethylated when compared with the rest of the genome ( Figure S6G ). It is tempting to speculate that conservation of methylation at these sites is relevant for human placental development, and that oocyte methylation evolved to play a major role in the trophoblast lineage.
EXPERIMENTAL PROCEDURES Mouse Lines and Tissue Preparation
All experimental procedures were performed under licenses by the Home Office (UK) in accordance with the Animals (Scientific Procedures) Act 1986. Mice carrying conditional deletions of both Dnmt3a and Dnmt3b (Okano et al., 1999) , or of Dnmt3a alone, and with or without a Zp3-Cre transgene were crossed by natural mating. Female mice heterozygous for an Ascl2-lacZ allele (Tanaka et al., 1999) were crossed to WT males. For immunofluorescence, E7.5 implantation sites were fixed with 4% paraformaldehyde (PFA) and processed as for routine paraffin histology. For RNA and DNA isolation, trophoblast and epiblast tissues were dissected from E7.5 or E9.5 conceptuses and snap-frozen.
Tissue Culture and Scml2 Overexpression/Knockout Blastocyst-derived TS-EGFP cells (a kind gift from Dr. Janet Rossant) or WT/ TKO TSCs derived from nuclear transfer embryos (Sakaue et al., 2010) were cultured under routine conditions (20% fetal bovine serum, 1 mM Na-pyruvate, penicillin/streptomycin, 50 mM 2-mercaproethanol, 25 ng/ml basic FGF (Sigma) and 1 mg/ml heparin in RPMI 1640, with 70% of the medium pre-conditioned on embryonic feeder cells). For Scml2 overexpression, the open reading frame of the isoform that starts at the intragenic CGI-associated TSS was cloned via Gateway cloning (Life Technologies) into a PiggyBac vector and sequence-verified. This construct or the empty vector were co-transfected with a PiggyBac transposase plasmid using Lipofectamine 2000 (Life Technologies) or Fugene 6 (Promega), according to the manufacturer's instructions. Integrants were selected with 5 mg/ml blasticidin S, after which cells were switched to TS cell differentiation medium (unconditioned medium without basic FGF or heparin) for the indicated times. For CRISPR/Cas9-mediated deletion of Scml2, TKO TSCs were co-transfected with pCAG-cGFPblasticidin and pCas9.2A.GFP/Puro (Ran et al., 2013) harboring guide RNAs flanking exon 3 ( Figure S6D ): GTTCATCCCTAGGCAATTAT, CAGGGA TGTTTGCAACGTGC. After 48 hr of blasticidin selection, single cells were sorted by flow cytometry and left to grow for 10-14 days before genotyping (see Supplemental Experimental Procedures, Primers).
Histology and Immunofluorescence
Paraffin sections were deparaffinized with Histo-Clear and dehydrated through an ethanol series, followed either by standard H&E staining or antigen retrieval by boiling slides for 30 min (in 1 mM EDTA, 0.05% Tween 20, pH 8) and cooling at room temperature for 20 min. After blocking with 1% BSA overnight, sections were incubated with a rabbit monoclonal anti-CDX2 antibody (EPR2764Y, Novus Biologicals, 1:250 dilution) for 2 hr. Secondary detection was done with an AlexaFluor 488 anti-rabbit antibody (Life Technologies, 1:500 dilution). TSCs were fixed with 4% PFA, permeabilized with Triton X-100, blocked as above, and labeled with a mouse anti-CDH1 antibody (BD 610181, BD Biosciences, 1:400 dilution).
Cell Adhesion Assay
Adhesion of TSCs to cell-culture wells was performed using the Vybrant cell adhesion assay kit (Life Technologies) according to the manufacturer's instructions, with the following details/modifications: 10 5 cells were plated per well of a 96-well tissue culture plate, either uncoated or coated with laminin, and left to attach for 2 hr in serum-free RPMI medium.
RNA/DNA Isolation and Bisulfite Conversion Genomic DNA and RNA were isolated from the same samples using the Allprep DNA/RNA Kit (Qiagen). RNA was DNase-treated with the DNA-free kit (Life Technologies). DNA was bisulfite-converted using the Imprint DNA Modification Kit (Sigma).
RT-qPCR
For RT-qPCR analysis, total RNA was reverse transcribed by random priming using the RevertAid First Strand cDNA Synthesis Kit (Thermo Scientific). qPCR was performed using Brilliant III Ultra-Fast SYBR Green qPCR Master Mix (Agilent Technologies) or Mesa Blue qPCR MasterMix Plus (Eurogentec) using gene-specific primers (see Supplemental Experimental Procedures).
Sequenom MassARRAY
PCR was performed on bisulfite-converted DNA using HotStarTaq DNA Polymerase (Qiagen) and target-specific primers (see Supplemental Experimental Procedures); samples were processed using the ''T'' Cleavage MassCLEAVE Reagent Kit (Agena Bioscience) and subjected to MALDI-TOF analysis using the MassARRAY system, according to the manufacturer's instructions.
RNA-Seq Library Generation and Sequencing mRNA was purified from 45-400 ng of total RNA using a Dynabeads mRNA Purification Kit (Life Technologies). For each genotype, three strand-specific libraries were generated from single EPCs using the ScriptSeq v2 RNA-Seq Library Preparation Kit (Epicentre), according to the manufacturer's instructions. Indexed libraries were pooled and sequenced on an Illumina HiSeq 2000 or 2500 platform using 50 bp (Dnmt3 libraries) or 100 bp (Ascl2 libraries) single-end reads. Reads were trimmed using ''Trim Galore!'' and mapped to the NCBIM37 genome assembly using TopHat (Trapnell et al., 2009 ).
BS-Seq Library Generation and Sequencing
Whole-genome BS-seq libraries were prepared from 25-70 ng of genomic DNA, using a post-bisulfite adaptor tagging protocol, as previously described (Peat et al., 2014) . In brief, first-strand synthesis was performed on bisulfiteconverted DNA using biotin-tagged random primers containing part of the Illumina-compatible 5 0 adaptor sequence. After biotin capture using Dynabeads (Life Technologies), second-strand synthesis was performed using random primers containing part of the Illumina-compatible 3 0 adaptor sequence.
DNA was then eluted from the beads and libraries amplified using Phusion (New England Biolabs). Libraries were sequenced on an Illumina HiSeq 2500 platform using 100-bp paired-end reads. Reads were trimmed using ''Trim Galore!'' and mapped to the NCBIM37 genome assembly using bismark .
Bioinformatics Analyses
All data analyses were performed using Seqmonk and/or R scripts. Differential gene expression analysis was performed with DEseq (Anders and Huber, 2010) , using a 1% false discovery rate cut-off and minimum fold change of 2. GO analysis was performed using topGO. To measure DNA methylation at given genomic features, methylation calls from both strands at CpG sites were pooled; regions that had at least three CpGs covered by at least five reads were selected and the average CpG methylation value per region calculated. Promoters were defined as À1 kb to +500 bp relative to each TSS; CGI annotation was from Illingworth et al. (2008) . For DMR detection, methylation calls from running windows containing five CpGs within 1 kb were pooled; significant differences were determined using a Fisher test and a BenjaminiHochberg corrected p value cut-off of 0.01. Significantly different windows within 200 bp were merged into DMRs, and only DMRs with a methylation difference larger than 20% were kept. LiftOver was used to identify regions of synteny to the identified DMRs in human. Of 4,084 syntenic regions identified, 353 were covered by at least five reads in human oocyte and morula reduced representation bisulfite sequencing data (Guo et al., 2014) and used for further analysis.
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